Results from The HUNT Study on The Role of Plasma miR-145-5p Levels in Cancer-Associated VTE – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Christopher Antoun et al, adding:
”Plasma miR-145-5p levels and risk of cancer-associated thrombosis — results from the HUNT study
Higher plasma miR-145-5p levels are significantly associated with reduced risk of both cancer-associated and non-cancer-associated venous thromboembolism, positioning this microRNA as a promising biomarker for thrombosis risk stratification in cancer patients.”
Title: Plasma miR-145-5p levels and risk of cancer-associated thrombosis—results from the HUNT study
Authors: Christopher Antoun, Julia Oto, Raquel Herranz, Pilar Medina, Vania M. Morelli, Kristian Hveem, Sigrid K. Brækkan, John-Bjarne Hansen
Read the Full Article on JTH
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 20, 2026, 16:31Jerome Winegarden: ASH Continues to Show Exceptional Leadership by Advocating for Patients With Blood Diseases
-
Mar 20, 2026, 16:28Breanna Beers: A Remarkable Case of ‘Generation Skipping’ Marfan Syndrome
-
Mar 20, 2026, 16:23Eva Soler Espejo։ Atherogenic Index of Plasma and Residual Risk in Atrial Fibrillation
-
Mar 20, 2026, 16:22Welcoming Samer Al Hadidi to the Blood Cancers Team – UT Southwestern Simmons Cancer Center
-
Mar 20, 2026, 16:21Maxime Dely: The Lifesaving Power of Plasma Donations
-
Mar 20, 2026, 16:20Yves Bikorimana: Hemolysis – Why It Ruins Laboratory Results
-
Mar 20, 2026, 16:19Simon Senanu: G6PD Deficiency Testing – What the Lab Must Get Right
-
Mar 20, 2026, 16:18Khaled Elshazly: Can We Stop Chemotherapy-Induced Thrombocytopenia from Delaying Treatment?
-
Mar 20, 2026, 15:50Rithwic Mani: Platelet-to-Lymphocyte Ratio as A Simple and Cost-Effective Prognostic Biomarker in Stroke